Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Cancer Res ; 69(10): 4454-60, 2009 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-19435904

RESUMO

Chromosomal instability is a hallmark of many tumor types. Complex chromosomal rearrangements with associated gene amplification, known as complicons, characterize many hematologic and solid cancers. Whereas chromosomal aberrations, including complicons, are useful diagnostic and prognostic cancer markers, their molecular origins are not known. Although accumulating evidence has implicated DNA double-strand break repair in suppression of oncogenic genome instability, the genomic elements required for chromosome rearrangements, especially complex lesions, have not been elucidated. Using a mouse model of B-lineage lymphoma, characterized by complicon formation involving the immunoglobulin heavy chain (Igh) locus and the c-myc oncogene, we have now investigated the requirement for specific genomic segments as donors for complex rearrangements. We now show that specific DNA double-strand breaks, occurring within a narrow segment of Igh, are necessary to initiate complicon formation. By contrast, neither specific DNA breaks nor the powerful intronic enhancer Emu are required for complicon-independent oncogenesis. This study is the first to delineate mechanisms of complex versus simple instability and the first to identify specific chromosomal elements required for complex chromosomal aberrations. These findings will illuminate genomic cancer susceptibility and risk factors.


Assuntos
Aberrações Cromossômicas , Dano ao DNA , Reparo do DNA , Amplificação de Genes , Rearranjo Gênico , Genes myc , Cadeias Pesadas de Imunoglobulinas/genética , Linfócitos/fisiologia , Linfoma de Células B/genética , Translocação Genética , Animais , Modelos Animais de Doenças , Predisposição Genética para Doença , Região de Junção de Imunoglobulinas/genética , Linfoma de Células B/epidemiologia , Linfoma de Células B/imunologia , Camundongos , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA